ArticleThe journal of allergy and clinical immunology. In practice2022

Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiency.

H Richard Droghini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.